SCHEMBL14256529

SCHEMBL14256529

COc1ccc(CNc2nc(NC3CCCC3)c3ccccc3n2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MERTK Q12866 6/20 0.72
▸ EHMT2 Q96KQ7 2/20 0.69
▸ DNMT3A Q9Y6K1 2/20 0.69
▸ APP P05067 6/20 0.61
▸ SLC2A1 P11166 1/20 0.59
▸ BCHE P06276 3/20 0.59
▸ ACHE P22303 3/20 0.59
▸ CXCR4 P61073 1/20 0.59
▸ EGFR P00533 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ NR2F2 P24468 1/20 0.53
▸ RAD52 P43351 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ UBE2N P61088 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14256778 0.90 MERTK (0.65) MERTKEHMT2DNMT3AAPPSLC2A1
SCHEMBL14256774 0.90 APP (0.60) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL14266672 0.88 MERTK (0.57) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL14256541 0.88 MERTK (0.63) MERTKEHMT2DNMT3AAPPSLC2A1
SCHEMBL14266664 0.87 APP (0.62) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL24649781 0.86 CXCR4 (0.63) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL30896224 0.86 CXCR4 (0.63) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL14256527 0.86 APP (0.64) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL14256532 0.86 EHMT2 (0.66) MERTKEHMT2DNMT3AAPPBCHE
SCHEMBL14256525 0.86 CXCR4 (0.56) MERTKEHMT2DNMT3AAPPBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity ANGION BIOMEDICA CORPORATION (US) 2008-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058312-A1 Modulators of hepatocyte growth factor/c-Met activity HGF, MET, HDGF MERTK 58/4885EHMT2 1177/4885DNMT3A 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback